These results, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 aid the strategy of focusing on ACKR3 as a novel approach to modulate the opioid technique, which could open new therapeutic avenues for opioid-similar Conditions. Observe: Effects may perhaps change https://richardn628lct4.webbuzzfeed.com/profile